Nitrosamine Impurities Affecting Drug-Drug Interaction Studies – Learn More

Streamlining Bioanalysis of Biologics

Peptides & oligos

Nihil distinctio, ante dolor fermentum fugit quo tristique, sollicitudin, assumenda, fuga ac! Felis rutrum? Dignissim fermentum molestie sagittis, class. Tempora eius viverra sint curabitur quam.


Leaders in Biological Drug Development

Unparalleled method development and validation of immunoassays and immunogenicity assays for.

  • Pegylated and non-peglyated therapeutic proteins
  • Peptide
  • Antibodies (intact fragments, single chain)
  • Fusion-proteins or -peptides

See our Biosimilars experience



Pharmacokinetic Assays

An array of GLP-certified immunoassay capabilities.

  • RIA and EIA Peptide
  • MSD
  • ECLA
  • AlphaLisa
  • LC-MS/MS

Check out our full list of Equipment



Immunogenicity Assays

An array of GLP-certified immunoassay capabilities.

  • Anti-drug antibody detection
  • Cell-based and ELISA neutralizing antibody assays
  • NanoLuc for high throughput antibody detection
  • Multiple platforms and matrices

Learn more about our immunogenicity assays